ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ASXSF Elysee Development Corp (PK)

0.23824
0.00 (0.00%)
Last Updated: 15:13:54
Delayed by 15 minutes
Share Name Share Symbol Market Type
Elysee Development Corp (PK) USOTC:ASXSF OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.23824 0.193 0.2607 0.00 15:13:54

Remedent Engages Liolios Group to Lead New Investor Relations Program

17/02/2009 1:30pm

Marketwired


Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Elysee Development (PK) Charts.

Remedent, Inc. (OTCBB: REMI), an international company specializing in the research, development, and manufacturing of oral care and cosmetic dentistry products, has engaged Liolios Group, Inc. to lead a new investor relations and financial communications program.

"Liolios Group brings a proven ability to generate results for emerging growth companies looking to build quality, long-term relationships with investors, analysts, money managers and institutions," said Remedent CEO Guy De Vreese. "We have arrived at a pivotal stage in our development that has made it important for a team of experienced professionals like Liolios Group to deliver our message more effectively to our shareholders and raise our profile in the investment community."

Liolios Group will collaborate with Remedent's management to redefine the company's message and outline a new communications strategy, including identifying key performance metrics investors should focus upon as they track the company's progress. Liolios Group will also schedule a number of conference calls, road shows, and financial conferences over the next several months, targeting investors and key influencers such as analysts, fund managers, investment advisors, and members of the financial press.

To receive a corporate profile on Remedent or schedule meetings with company management, please contact Liolios Group at (949) 574-3860 or email info@liolios.com.

About Liolios Group

Liolios Group, Inc. is a highly selective and comprehensive investor relations firm specializing in small and micro-cap companies. The company aims to deliver superior performance in corporate messaging and positioning, investor awareness, analyst and financial press coverage, and capital attraction. Founded in 1996 in Newport Beach, California, Liolios Group partners all have more than 15 years experience in finance and investments, and have represented more than 100 companies in a wide range of industries. For more information about Liolios Group, go to www.liolios.com.

About Remedent

Remedent, Inc. specializes in the research, development, manufacturing and marketing of oral care and cosmetic dentistry products. The company serves the dental community with unique veneer, teeth whitening and sensitivity products that are recognized for their technological superiority and ease-of-application. Headquartered in Belgium, and with offices in California and Singapore, Remedent distributes its products to more than 35 countries worldwide.

Company Contacts: Stephen Ross CFO Remedent, Inc. Tel 310-922-5685 Email Contact Investor Relations: Ron Both Managing Director Liolios Group, Inc. Tel (949) 574-3860 Email Contact

1 Year Elysee Development (PK) Chart

1 Year Elysee Development (PK) Chart

1 Month Elysee Development (PK) Chart

1 Month Elysee Development (PK) Chart

Your Recent History

Delayed Upgrade Clock